Godrej Agrovet

Q3 FY26Food Products

Godrej Agrovet Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹610

Market cap₹11.1K Cr

P/E23.6

Updated26 Aug 2026

Read4 min read

The short version

FY '27 growth guidance around 15%, lower than previous targets of 25-30% due to ongoing detailed planning and market assessment (Page 19). FY '27 growth guidance is initially targeted at about 15% revenue growth, which is lower than past guidance of 25-30%, but this is preliminary and subject to annual planning completion by March.

From Godrej Agrovet's Q3 FY26 earnings-call transcript · updated 26 Aug 2026.

Revenue & Sales Performance

FY '27 growth guidance around 15%, lower than previous targets of 25-30% due to ongoing detailed planning and market assessment (Page 19).
Foods business aims to be a meaningful growth driver, focusing on value-added branded products, innovation, and go-to-market execution (Page 19).
Animal Feed segment—cattle feed volume growth around 16.5% for 9 months, indicating strong ongoing momentum (Page 15).
Oil palm business expects Fresh Fruit Bunch (FFB) tonnage growth of 12-15% CAGR on a steady-state basis driven by expanded acreage and farmer engagement (Page 9).
Astec LifeSciences targets approx. 15% revenue growth next year, mainly led by CDMO segment, following a recovery and positive EBITDA trend (Page 17).
Crop Protection expects to maintain midterm margins around 28-30% with sustained revenue growth post unseasonal weather impacts (Page 16).

Profitability & Margins

FY '27 growth guidance is initially targeted at about 15% revenue growth, which is lower than past guidance of 25-30%, but this is preliminary and subject to annual planning completion by March. (Page 19)
Astec LifeSciences targets EBITDA breakeven in FY '26 and about 15% revenue growth for the following year, driven mainly by CDMO business. (Page 17)
Crop Protection margins are expected to sustain at 28-30%, considered upper-end industry levels. (Page 17)
Value-added product contribution, especially in the Vegetable Oil business, is set to increase with new refinery capex coming online, leading to faster profit growth in that segment. (Page 10)
Foods business aims for meaningful growth focusing on value-added branded products, food innovation, and go-to-market investments to improve margins and topline over 2-3 years. (Page 19)
Dairy business maintaining gross margin expansion despite inflation; confident of stable milk procurement and growth outlook. (Pages 17, 9)

See what Godrej Agrovet said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

New CPO processing plant in Khammam to go live within 2 months.
Downstream refinery for value-added products (cocoa butter substitute, cocoa butter equivalent, CPKO refining) to be commissioned by Q1 of the coming year.
These capex projects will significantly ramp up downstream value-added product capacity, increasing contribution from ~8% currently to rapid growth.
In Crop Protection, planned launch of 2 in-house products in FY '27.
Continuing investment in product pipeline diversification (e.g., Ashitaka maize herbicide launched; Takai multi-crop insecticide launching soon).
Strategic focus on capital allocation to prioritized businesses aligned with market attractiveness, growth potential, profitability, and return on capital employed.
Detailed portfolio choices and value creation strategy to be communicated in April (potential structural calls on businesses, but specifics premature).

Top-ranked in Food Products

Ranked on what management guided this quarter

5x potential

1Nurture Well Industries Ltd₹489 Cr

Rev 1Mar 1

2HOACFOODS₹439 Cr

Rev 1Mar 1

3₹1.2K Cr

Rev 1Mar 3

4₹205 Cr

Rev 1Mar 3

5₹595 Cr

Rev 2Mar 1

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The transcript on the provided pages does not explicitly mention any current or upcoming fundraising plans through debt or equity for Godrej Agrovet Limited. However, the following related points can be noted: - The company is in the middle of annual operating exercises and strategic portfolio discussions, with some structural calls on capital allocation expected. - There are mentions of capital allocation priorities towards businesses with higher growth and profitability. - Specific funding or fundraising activities (debt or equity) are not detailed or explicitly stated. - The discussion hints at potential future announcements related to portfolio restructuring, value creation, or capital allocation, but nothing concrete on fundraising. In summary, there is no direct information on current or future new fundraising via debt or equity in the provided pages.

See what Godrej Agrovet said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided pages from the Godrej Agrovet Limited report do not contain specific information regarding the current or expected order book or pending orders. The discussion mainly focuses on: - Business segments like triazoles, milk procurement, crop protection, and animal feed. - Operational updates and growth outlooks. - Margins and product portfolio expansion. - Strategic initiatives and value unlocking discussions. - Market conditions and competitive positioning. There is no explicit mention or data related to the order book or pending orders in the excerpts given.

Godrej Agrovet — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹2.3K Cr, net profit ₹102 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Godrej Agrovet's management said in earlier quarters

Others in Food Products this season

Madhusudan Masa (Q3 FY26)
Capacity utilization of existing units is near full (Unit 1 at 98%, Unit 2 at 100%). Key concall takeaways from Madhusudan Masa's Q3 FY26 earnings call — and…
Ganesh Consumer (Q3 FY26)
January month showed a strong volume growth of ~9% in B2C category, indicating positive momentum (Pages 13,16,17). Key concall takeaways from Ganesh Consumer…
Britannia Inds. (Q3 FY26)
Potential to move towards 15% top-line growth with underlying volume growth near 9% plus additional impact from grammage changes post-GST. Key concall…
Avanti Feeds (Q3 FY26)
. Key concall takeaways from Avanti Feeds Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.

Compare:vs Nestle India vs Britannia Inds.vs Hatsun Agro Product Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Godrej Agrovet Q3 FY26 results?

What is Godrej Agrovet share price analysis?

Godrej Agrovet currently shows a neutral. The stock trades at a P/E of 23.6 with a market cap of ₹11,052 Cr. Investors should review the full earnings analysis for detailed insights.

Is Godrej Agrovet planning capital expenditure?

New CPO processing plant in Khammam to go live within 2 months.

Keep Godrej Agrovet on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.